Revenue
$5.10B
Fiscal year ended 2025-12-31Operating income
$113.00M
Fiscal year ended 2025-12-31Free cash flow
-$66.00M
Fiscal year ended 2025-12-31Bausch & Lomb Corp (BLCO) reported revenue of $5.10B and net income of -$360.00M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Bausch & Lomb Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Ophthalmic Goods.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | $5.10B | $4.79B | $4.15B | $3.77B | $3.76B | $3.41B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $113.00M | $162.00M | $130.00M | $207.00M | $329.00M | $260.00M |
| Net income | -$360.00M | -$317.00M | -$260.00M | $6.00M | $182.00M | -$18.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 353.80M | shares 351.80M | shares 350.50M | shares 350.20M | shares 350.00M | shares 350.00M |
| Pretax income | -$317.00M | -$234.00M | -$166.00M | $73.00M | $318.00M | $290.00M |
| Income tax expense | $35.00M | $71.00M | $82.00M | $58.00M | $125.00M | $307.00M |
| Diluted EPS | $-1.02 | $-0.90 | $-0.74 | $0.02 | $0.52 | $-0.05 |
| Selling, general & administrative | $2.23B | $2.08B | $1.74B | $1.48B | $1.39B | $1.25B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $383.00M | $305.00M | $331.00M | $354.00M | $174.00M | Unavailable |
| Total assets | $14.02B | $13.47B | $13.44B | $11.14B | $10.82B | Unavailable |
| Current assets | $2.98B | $2.79B | $2.74B | $2.14B | $1.64B | Unavailable |
| Total liabilities | $7.50B | $6.92B | $6.52B | $4.04B | $1.42B | Unavailable |
| Current liabilities | $1.92B | $1.74B | $1.58B | $1.30B | $1.10B | Unavailable |
| Total equity incl. NCI | $6.52B | $6.54B | $6.92B | $7.10B | $9.40B | $9.99B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $976.00M | $1.04B | $1.03B | $628.00M | $572.00M | Unavailable |
| Accounts receivable | $1.22B | $1.03B | $839.00M | $724.00M | $721.00M | Unavailable |
| Goodwill | $4.76B | $4.52B | $4.58B | $4.51B | $4.59B | $4.68B |
| Long-term debt | $5.02B | $4.74B | $4.53B | $2.41B | $0 | Unavailable |
| Accounts payable | $388.00M | $389.00M | $522.00M | $370.00M | $239.00M | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Operating cash flow | $283.00M | $232.00M | -$17.00M | $345.00M | $873.00M | $522.00M |
| Capital expenditures | $349.00M | $291.00M | $181.00M | $175.00M | $193.00M | $253.00M |
| Investing cash flow | -$455.00M | -$412.00M | -$2.11B | -$215.00M | -$214.00M | -$256.00M |
| Financing cash flow | $225.00M | $178.00M | $2.08B | $81.00M | -$712.00M | -$232.00M |
| Net change in cash | $81.00M | -$18.00M | -$46.00M | $203.00M | -$61.00M | $46.00M |
| Stock-based compensation | $149.00M | $92.00M | $74.00M | $62.00M | $62.00M | $50.00M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $421.00M | $436.00M | $382.00M | $379.00M | $415.00M | $442.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Free cash flow | -$66.00M | -$59.00M | -$198.00M | $170.00M | $680.00M | $269.00M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% |
| FCF margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% | 7.9% |
| SBC / revenue | 2.9% | 1.9% | 1.8% | 1.6% | 1.6% | 1.5% |
| Current ratio | 1.55x | 1.60x | 1.74x | 1.65x | 1.49x | Unavailable |
| Revenue YoY growth | 6.5% | 15.6% | 10.0% | 0.1% | 10.3% | Unavailable |
| Net margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 6.8% | 6.1% | 4.4% | 4.6% | 5.1% | 7.4% |
| Long-term debt / equity | 0.77x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | 79.5% | 39.3% | 105.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BLCO in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-30View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.